Porter Breast Center becomes one of the only NAPBC-accredited programs in Colorado

NewsGuard 100/100 Score

Porter Adventist Hospital is happy to announce that the Porter Breast Center, a regional destination for comprehensive breast care and part of the Centura Health Cancer Network, has been reaccredited by the American College of Surgeons, National Accreditation Program for Breast Centers (NAPBC) with a three-year full accreditation.

The Porter Breast Center is one of the only NAPBC-accredited programs in Colorado and has continually shown excellence in the areas of leadership, clinical management, research, community outreach, professional expertise and overall quality.

NAPBC accreditation is the gold standard for breast care centers that evaluates a wide spectrum of services that include prevention, early detection, diagnosis, treatment, rehabilitation, multidisciplinary care teams and genetic counseling. To receive NAPBC accreditation, a breast center must undergo a rigorous evaluation and review of their performance and adherence to national standards. Based on these stringent, nationally recognized, and evidence-based quality measures, accreditation is granted only to those centers that provide the best possible care.

The Porter Breast Center is one of five accredited cancer centers in the Centura Health Cancer Network, which delivers integrated, advanced cancer care across Colorado and western Kansas. By using an integrative approach that links some of the region's brightest minds in cancer care, the Centura Health Cancer Network offers a complete array of treatment services, connecting patients with cancer and blood disorders to the most advanced care available in region.

Source:

Porter Adventist Hospital

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer